{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:21:25Z","timestamp":1787228485913,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T00:00:00Z","timestamp":1567382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T00:00:00Z","timestamp":1567382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente."],"award-info":[{"award-number":["Ricerca Corrente."]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10072-019-04061-5","type":"journal-article","created":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T18:22:29Z","timestamp":1567448549000},"page":"131-138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia\u2014an observational study"],"prefix":"10.1007","volume":"41","author":[{"given":"Anna","family":"Castagna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3051-1031","authenticated-orcid":false,"given":"Antonio","family":"Caronni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Scium\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Giacobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Corrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Montesano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Ramella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,2]]},"reference":[{"key":"4061_CR1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese A, Bhatia K, Bressman SB, DeLong MR, Fahn S, Fung VSC, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord 28:863\u2013873","journal-title":"Mov Disord"},{"key":"4061_CR2","doi-asserted-by":"publisher","first-page":"950","DOI":"10.2340\/16501977-1055","volume":"44","author":"L Zetterberg","year":"2012","unstructured":"Zetterberg L, Lindmark B, S\u00f6derlund A, \u00c5senl\u00f6f P (2012) Self-perceived non-motor aspects of cervical dystonia and their association with disability. J Rehabil Med 44:950\u2013954","journal-title":"J Rehabil Med"},{"key":"4061_CR3","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/jnnp.72.5.608","volume":"72","author":"Y Ben-Shlomo","year":"2002","unstructured":"Ben-Shlomo Y, Camfield L, Warner T (2002) What are the determinants of quality of life in people with cervical dystonia? J Neurol Neurosurg Psychiatry 72:608\u2013614","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4061_CR4","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","volume":"86","author":"DM Simpson","year":"2016","unstructured":"Simpson DM, Hallett M, Ashman EJ et al (2016) Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 86:1818\u20131826","journal-title":"Neurology"},{"key":"4061_CR5","doi-asserted-by":"crossref","unstructured":"Castelao M, Marques RE, Duarte GS, et al (2017) Botulinum toxin type A therapy for cervical dystonia. Cochrane Libr","DOI":"10.1002\/14651858.CD003633.pub3"},{"key":"4061_CR6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00415-014-7586-2","volume":"262","author":"C Comella","year":"2015","unstructured":"Comella C, Bhatia K (2015) An international survey of patients with cervical dystonia. J Neurol 262:837\u2013848","journal-title":"J Neurol"},{"key":"4061_CR7","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s00415-013-7220-8","volume":"261","author":"J De Pauw","year":"2014","unstructured":"De Pauw J, der Velden K, Meirte J et al (2014) The effectiveness of physiotherapy for cervical dystonia: a systematic literature review. J Neurol 261:1857\u20131865","journal-title":"J Neurol"},{"key":"4061_CR8","first-page":"219","volume":"18","author":"N Smania","year":"2003","unstructured":"Smania N, Corato E, Tinazzi M et al (2003) The effect of two different rehabilitation treatments in cervical dystonia: preliminary results in four patients. Funct Neurol 18:219\u2013226","journal-title":"Funct Neurol"},{"key":"4061_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1177\/0269215512456221","volume":"27","author":"MJ Boyce","year":"2013","unstructured":"Boyce MJ, Canning CG, Mahant N, Morris J, Latimer J, Fung VSC (2013) Active exercise for individuals with cervical dystonia: a pilot randomized controlled trial. Clin Rehabil 27:226\u2013235","journal-title":"Clin Rehabil"},{"key":"4061_CR10","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1177\/1545968313491010","volume":"27","author":"E Pelosin","year":"2013","unstructured":"Pelosin E, Avanzino L, Marchese R, Stramesi P, Bilanci M, Trompetto C, Abbruzzese G (2013) Kinesiotaping reduces pain and modulates sensory function in patients with focal dystonia: a randomized crossover pilot study. Neurorehabil Neural Repair 27:722\u2013731","journal-title":"Neurorehabil Neural Repair"},{"key":"4061_CR11","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1002\/mds.22608","volume":"24","author":"CCS Delnooz","year":"2009","unstructured":"Delnooz CCS, Horstink MWIM, Tijssen MA, van de Warrenburg BPC (2009) Paramedical treatment in primary dystonia: a systematic review. Mov Disord Off J Mov Disord Soc 24:2187\u20132198","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"4061_CR12","first-page":"1193","volume":"121","author":"N Hill","year":"1979","unstructured":"Hill N, Frappier-Davignon L, Morrison B (1979) The periodic health examination. Can Med Assoc J 121:1193\u20131254","journal-title":"Can Med Assoc J"},{"key":"4061_CR13","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/mds.21145","volume":"21","author":"C Tassorelli","year":"2006","unstructured":"Tassorelli C, Mancini F, Balloni L, Pacchetti C, Sandrini G, Nappi G, Martignoni E (2006) Botulinum toxin and neuromotor rehabilitation: an integrated approach to idiopathic cervical dystonia. Mov Disord Off J Mov Disord Soc 21:2240\u20132243","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"4061_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajo.2010.08.047","volume":"151","author":"JH Kempen","year":"2011","unstructured":"Kempen JH (2011) Appropriate use and reporting of uncontrolled case series in the medical literature. Am J Ophthalmol 151:7\u201310","journal-title":"Am J Ophthalmol"},{"key":"4061_CR15","first-page":"375","volume":"14","author":"J Korein","year":"1976","unstructured":"Korein J, Brudny J, Grynbaum B et al (1976) Sensory feedback therapy of spasmodic torticollis and dystonia: results in treatment of 55 patients. Adv Neurol 14:375","journal-title":"Adv Neurol"},{"key":"4061_CR16","first-page":"259","volume":"14","author":"CD Marsden","year":"1976","unstructured":"Marsden CD (1976) The problem of adult-onset idiopathic torsion dystonia and other isolated dyskinesias in adult life (including blepharospasm, oromandibular dystonia, dystonic writer\u2019s cramp, and torticollis, or axial dystonia). Adv Neurol 14:259\u2013276","journal-title":"Adv Neurol"},{"key":"4061_CR17","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1093\/brain\/aww141","volume":"139","author":"AG Shaikh","year":"2016","unstructured":"Shaikh AG, Zee DS, Crawford JD, Jinnah HA (2016) Cervical dystonia: a neural integrator disorder. Brain 139:2590\u20132599","journal-title":"Brain"},{"key":"4061_CR18","doi-asserted-by":"publisher","first-page":"e00735","DOI":"10.1002\/brb3.735","volume":"7","author":"J De Pauw","year":"2017","unstructured":"De Pauw J, Mercelis R, Hallemans A et al (2017) Cervical sensorimotor control in idiopathic cervical dystonia: a cross-sectional study. Brain Behav 7:e00735","journal-title":"Brain Behav"},{"key":"4061_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/0883073810371828","volume":"26","author":"SJ Young","year":"2011","unstructured":"Young SJ, van Doornik J, Sanger TD (2011) Visual feedback reduces co-contraction in children with dystonia. J Child Neurol 26:37\u201343","journal-title":"J Child Neurol"},{"key":"4061_CR20","doi-asserted-by":"crossref","unstructured":"Anna Castagna AA (2018) Management of cervical dystonia with botulinum neurotoxins and EMG\/ultrasound guidance. Neurol Clin Pract 029785a","DOI":"10.1212\/CPJ.0000000000000568"},{"key":"4061_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.toxicon.2018.01.018","volume":"147","author":"J Wissel","year":"2018","unstructured":"Wissel J (2018) Towards flexible and tailored botulinum neurotoxin dosing regimens for focal dystonia and spasticity--insights from recent studies. Toxicon 147:100\u2013106","journal-title":"Toxicon"},{"key":"4061_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/toxins8030065","volume":"8","author":"F Scaglione","year":"2016","unstructured":"Scaglione F (2016) Conversion ratio between Botox\u00ae, Dysport\u00ae, and Xeomin\u00ae in clinical practice. Toxins (Basel) 8:65","journal-title":"Toxins (Basel)"},{"key":"4061_CR23","first-page":"445","volume":"40","author":"ES Consky","year":"1990","unstructured":"Consky ES, Basinski A, Belle L et al (1990) The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS): assessment of validity and inter-rater reliability. Neurology 40:445","journal-title":"Neurology"},{"key":"4061_CR24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/mds.24949","volume":"27","author":"S Lalli","year":"2012","unstructured":"Lalli S, Piacentini S, Franzini A, Panzacchi A, Cerami C, Messina G, Ferr\u00e9 F, Perani D, Albanese A (2012) Epidural premotor cortical stimulation in primary focal dystonia: clinical and 18F-fluoro deoxyglucose positron emission tomography open study. Mov Disord 27:533\u2013538","journal-title":"Mov Disord"},{"key":"4061_CR25","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3111\/13696998.2014.953680","volume":"17","author":"M-H Jen","year":"2014","unstructured":"Jen M-H, Kurth H, Iheanacho I, Dinet J, Gabriel S, Wasiak R, Jost WH (2014) Assessing the burden of illness from cervical dystonia using the Toronto Western Spasmodic Torticollis Rating Scale scores and health utility: a meta-analysis of baseline patient-level clinical trial data. J Med Econ 17:803\u2013809","journal-title":"J Med Econ"},{"key":"4061_CR26","unstructured":"Jankovic J (1994) Therapy with botulinum toxin. Marcel Dekker"},{"key":"4061_CR27","unstructured":"Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 65\u201370"},{"key":"4061_CR28","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1080\/09638288.2016.1194486","volume":"39","author":"A Caronni","year":"2017","unstructured":"Caronni A, Scium\u00e8 L (2017) Is my patient actually getting better? Application of the McNemar test for demonstrating the change at a single subject level. Disabil Rehabil 39:1341\u20131347","journal-title":"Disabil Rehabil"},{"key":"4061_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/BF02293814","volume":"43","author":"D Andrich","year":"1978","unstructured":"Andrich D (1978) A rating formulation for ordered response categories. Psychometrika 43:561\u2013573","journal-title":"Psychometrika"},{"key":"4061_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF02296272","volume":"47","author":"GN Masters","year":"1982","unstructured":"Masters GN (1982) A rasch model for partial credit scoring. Psychometrika 47:149\u2013174. https:\/\/doi.org\/10.1007\/BF02296272","journal-title":"Psychometrika"},{"key":"4061_CR31","unstructured":"R Core Team (2017) R: a language and environment for statistical computing"},{"key":"4061_CR32","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","volume":"70","author":"DM Simpson","year":"2008","unstructured":"Simpson DM, Blitzer A, Brashear A et al (2008) Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70:1699\u20131706","journal-title":"Neurology"},{"key":"4061_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-1331.2010.03125.x","volume":"17","author":"A Esquenazi","year":"2010","unstructured":"Esquenazi A, Novak I, Sheean G, Singer BJ, Ward AB (2010) International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments--introduction. Eur J Neurol 17:1\u20138","journal-title":"Eur J Neurol"},{"key":"4061_CR34","doi-asserted-by":"crossref","unstructured":"Marques RE, Duarte GS, Rodrigues FB, et al (2016) Botulinum toxin type B for cervical dystonia. Cochrane Libr","DOI":"10.1002\/14651858.CD004315.pub3"},{"key":"4061_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000370245","volume":"95","author":"E Yiannakopoulou","year":"2015","unstructured":"Yiannakopoulou E (2015) Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin. Pharmacology 95:65\u201369","journal-title":"Pharmacology"},{"key":"4061_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/mdc3.12613","volume":"5","author":"J Jankovic","year":"2018","unstructured":"Jankovic J, Truong D, Patel AT, Brashear A, Evatt M, Rubio RG, Oh CK, Snyder D, Shears G, Comella C (2018) Injectable DaxibotulinumtoxinA in cervical dystonia: a phase 2 dose-escalation multicenter study. Mov Disord Clin Pract 5:273\u2013282","journal-title":"Mov Disord Clin Pract"},{"key":"4061_CR37","doi-asserted-by":"crossref","unstructured":"Jankovic J, Truong D, Patel A, et al (2018) Outcomes of week-24 completers and subjects who had follow-up beyond week 24 after a single treatment of DaxibotulinumtoxinA for injection (RT002): results of a phase 2, open-label (level II), dose escalating study in isolated cervical dystonia (P5. 037)","DOI":"10.1212\/WNL.90.15_supplement.P5.037"},{"key":"4061_CR38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1600-0404.2008.01111.x","volume":"119","author":"L Zetterberg","year":"2009","unstructured":"Zetterberg L, Aquilonius S-M, Lindmark B (2009) Impact of dystonia on quality of life and health in a Swedish population. Acta Neurol Scand 119:376\u2013382","journal-title":"Acta Neurol Scand"},{"key":"4061_CR39","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10072-017-2839-3","volume":"38","author":"G Defazio","year":"2017","unstructured":"Defazio G, Esposito M, Abbruzzese G, Scaglione CL, Fabbrini G, Ferrazzano G, Peluso S, Pellicciari R, Gigante AF, Cossu G, Arca R, Avanzino L, Bono F, Mazza MR, Bertolasi L, Bacchin R, Eleopra R, Lettieri C, Morgante F, Altavista MC, Polidori L, Liguori R, Misceo S, Squintani G, Tinazzi M, Ceravolo R, Unti E, Magistrelli L, Coletti Moja M, Modugno N, Petracca M, Tambasco N, Cotelli MS, Aguggia M, Pisani A, Romano M, Zibetti M, Bentivoglio AR, Albanese A, Girlanda P, Berardelli A (2017) The Italian Dystonia Registry: rationale, design and preliminary findings. Neurol Sci 38:819\u2013825","journal-title":"Neurol Sci"},{"key":"4061_CR40","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.2147\/PPA.S106560","volume":"10","author":"M Poliziani","year":"2016","unstructured":"Poliziani M, Koch M, Liu X (2016) Striving for more good days: patient perspectives on botulinum toxin for the treatment of cervical dystonia. Patient Prefer Adherence 10:1601","journal-title":"Patient Prefer Adherence"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04061-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-019-04061-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04061-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T21:39:10Z","timestamp":1721684350000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-019-04061-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["4061"],"URL":"https:\/\/doi.org\/10.1007\/s10072-019-04061-5","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,2]]},"assertion":[{"value":"11 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical aspects of the study were reviewed and approved by the local ethic committee (Comitato Etico \u201cIRCCS Fondazione Don Carlo Gnocchi\u201d, Comitato Etico Centrale IRCCS Regione Lombardia) and the study has been recorded at(NCT03247868). Each participant gave his\/her written consent to take part in the study. The patient who agreed to appear in the video attached to the current work as Supplementary Materialsgave her written consent to publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The other authors declare that they have no conflicts of interest. Alessandro Crippa created the feedback system used in the study (Leonardo, produced by Chinesport).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}